SGN-CD352A: A novel humanized anti-CD352 antibody -drug conjugate for the treatment of multiple myeloma

被引：10
|
作者：
Lewis, Tim
Olson, Devra J.
Gordon, Kristine A.
Sandal, Sharsti L.
Miyamoto, Jamie
VVestendorf, Lori
Linares, Germein
Leiske, Chris
Kostner, Heather
Stone, Ivan
Anderson, Martha
Nesterova, Albina
Jonas, Mechthild
Law, Che-Leung
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1195
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1195
引用
收藏
页数：3
相关论文
共 50 条
  • [21] CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
    Nishida, Hiroko
    Hayashi, Mutsumi
    Morimoto, Chikao
    Sakamoto, Michiie
    Yamada, Taketo
    BLOOD CANCER JOURNAL, 2018, 8
  • [22] CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
    Hiroko Nishida
    Mutsumi Hayashi
    Chikao Morimoto
    Michiie Sakamoto
    Taketo Yamada
    Blood Cancer Journal, 8
  • [23] Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells
    Sherbenou, Daniel W.
    Aftab, Blake T.
    Su, Yang
    Behrens, Christopher R.
    Wiita, Arun
    Logan, Aaron C.
    Acosta-Alvear, Diego
    Hann, Byron C.
    Walter, Peter
    Shuman, Marc A.
    Wu, Xiaobo
    Atkinson, John P.
    Wolf, Jeffrey L.
    Martin, Thomas G.
    Liu, Bin
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (12): : 4640 - 4653
  • [24] Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40
    Law, CL
    Gordon, KA
    Collier, J
    Klussman, K
    McEarchern, JA
    Cerveny, CG
    Mixan, BJ
    Lee, WP
    Lin, ZH
    Valdez, P
    Wahl, AF
    Grewal, IS
    CANCER RESEARCH, 2005, 65 (18) : 8331 - 8338
  • [25] Immune modulation mediated by the humanized anti-CD70 monoclonal antibody SGN-70
    Klussman, Kerry
    McEarchern, Julie A.
    Oflazoglu, Ezogelin
    Williams, Kacy
    Smith, Leia M.
    Nesterova, Albina
    Gerber, Hans-Peter
    Grewal, Iqbal S.
    Law, Che-Leung
    FASEB JOURNAL, 2008, 22
  • [26] DARATUMUMAB Anti-CD38 Monoclonal Antibody, Treatment of Multiple Myeloma
    Richardson, P.
    Lokhorst, H.
    Palumbo, A.
    Nahi, H.
    Laubach, J.
    Gimsing, P.
    Lisby, S.
    Cakana, A.
    Brun, N. Constantin
    Plesner, T.
    DRUGS OF THE FUTURE, 2013, 38 (08) : 545 - 554
  • [27] Preclinical pharmacokinetics and pharmacodynamics of SGN-40, a humanized anti-CD40 antibody.
    Miller, DM
    Kelley, S
    Gelzleichter, T
    Grewal, L
    Darbonne, WC
    BLOOD, 2003, 102 (11) : 689A - 689A
  • [28] Preclinical antitumor activity of a humanized anti-CD40 monoclonal antibody SGN-40.
    Law, CL
    Lee, WP
    Lin, ZH
    Grewal, IS
    Wahl, A
    BLOOD, 2003, 102 (11) : 646A - 646A
  • [29] CD70 expression in multiple types of carcinomas: new targets for auristatin-based anti-CD70 antibody-drug conjugate, SGN-75
    Smith, Leia
    Kostner, Heather
    Duniho, Steven
    Nesterova, Albina
    Sutherland, May
    Yu, Changpu
    Kim, Kristine
    Gordon, Kristine
    McEarchern, Julie
    Law, Che-Leung
    Ryan, Maureen
    CANCER RESEARCH, 2009, 69
  • [30] Brentuximab Vedotin (SGN-35), an antibody-drug conjugate for the treatment of CD30-positive malignancies
    Gualberto, Antonio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (02) : 205 - 216
12345